INTRODUCTION
============

The irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by abdominal pain or discomfort associated with stool quality or frequency ([@bib1]). The financial impact of IBS on society is high because of medical costs, absenteeism from work, and impaired health-related quality of life ([@bib2]). In recent years, clinicians have observed an increasing overlap of clinical and pathophysiologic features that typically distinguish functional from organic disorders--that is, a blurring of the boundaries of the dualistic biomedical dichotomy ([@bib3]). For major example, many patients with inflammatory bowel disease (IBD) in clinical remission continue to have symptoms of pain and diarrhea despite minimal or no ongoing inflammation. These patients may be considered to have overlap of IBD and IBS ([@bib4]).

A subset of patients with colonic diverticular disease (DD) has chronic gastrointestinal symptoms, and some have a clinical diagnosis of IBS, but whether IBS and DD are linked is uncertain. Jung *et al.* ([@bib5]) showed that the presence of colonic DD has been associated with higher risks of IBS and diarrhea-predominant IBS (D-IBS), whereas most patients with diverticulosis are asymptomatic. Cohen *et al.* ([@bib6]) also reported that patients with a history of diverticulitis could be at risk for later development of IBS and functional bowel disorders. These studies showed important epidemiological associations between DD and IBS. However, there are several points in developing a deeper understanding of the association between DD and IBS. Above all, previous studies were conducted in Western countries ([@bib5], [@bib6]). One major difference between colonic DD in the West and Asia is the predominant location. In European and US populations, DD arises mainly in the distal colon, with 90% of patients having sigmoid colon involvement and only approximately 15% having right-sided disease ([@bib7]). However, in Asian populations, DD is mainly right-sided ([@bib8]). Why is the location of DD important? Faucheron *et al.* ([@bib9]) reported that right-sided localization of DD is associated with a risk of bleeding, Law *et al.* ([@bib10]) showed that left-sided diverticulitis tended to become severe, and we showed that development of left-sided diverticulitis was associated with visceral obesity ([@bib11]). These studies show that the risk of onset or severity of DD depends on the location. However, there are no previous reports showing an association between the location of DD and IBS. Also, gastrointestinal physiology may vary between Asian and Western populations because of differences in diet, sociocultural background, and genetic factors ([@bib12]). Therefore, we must evaluate the association between DD and IBS in the Japanese population to develop a deeper understanding of the association between DD and IBS.

METHODS
=======

This study was a multicenter study conducted with the approval of the Ethics Committee of Yokohama City University (approval number B130307045) and each center. Examination was performed after registering the trial with the University Hospital Medical Information Network in Japan (registration number R000012739).

Subjects and survey method
--------------------------

This study was performed in seven centers (Yokohama City University Hospital, Machida Municipal Hospital, Yokosuka City Hospital, Yokohama Minami Kyosai Hospital, NTT Medical Center Tokyo, International University of Health and Welfare Atami Hospital, and Tokyo Metropolitan Hiroo General Hospital) from June 2013 to September 2013. Each hospital is a flagship hospital in each region. Study subjects were consecutive Japanese patients who underwent total colonoscopy at each center, and the reason for colonoscopy was colon and rectal cancer screening. We excluded patients with active intra-abdominal and pelvic malignancy, ulcerative colitis, Crohn\'s disease, microscopic colitis, and other organic gastrointestinal disorders as in previous reports ([@bib5]). We also excluded patients with a history of intestinal resection. The diagnosis of diverticulosis was established by colonoscopy with transparent soft-short-hood and diverticulosis was defined by the presence of one diverticulum or multiple diverticula. DD is the combination of a past history of diverticulitis and the diverticulosis. The location of DD was defined as follows: left-sided colon was defined as sigmoid colon, descending colon, and rectum, and right-sided colon was defined as cecum, ascending colon, and transverse colon.

Diagnosis of IBS
----------------

We used a questionnaire to diagnose IBS and to collect the necessary information before colonoscopy in all subjects. IBS: Subjects were classified as having IBS on the basis of the symptoms recorded in the questionnaire. IBS and the IBS subtype were defined using Rome III criteria ([@bib1]). The definition applied required recurrent abdominal pain or discomfort frequency of at least 2 days a week with at least two of the following ([@bib1]): improvement with defecation ([@bib2]); onset associated with a change in frequency of stool; and ([@bib3]) onset associated with a change in the form of stool. Stool form was assessed using the Bristol scale ([@bib13]). IBS was sub-typed as (i) D-IBS: IBS with loose or watery stools for at least 25% of bowel movements, and hard or lumpy stool for \<25% of the bowel movements; (ii) constipation-predominant IBS: IBS with hard or lumpy stool for at least 25% of the bowel movements, and loose or watery stools for \<25% of the bowel movements; (iii) mixed IBS: meeting the criteria for both D-IBS and constipation-predominant IBS; and (iv) un-subtype IBS (U-IBS): IBS not meeting the criteria for the other three categories ([@bib1]).

Additional information
----------------------

Additional information was gathered from the questionnaire before undergoing colonoscopy:

\(i\)   Demographics: age and gender.

\(ii\) Body mass index (BMI): based on self-recording of height and current weight.

\(iii\)   Mental health status was evaluated using SF-8 ([@bib14]). The SF-8 is a generic questionnaire derived from the longer 36-item Short-Form Health Survey (SF-36) and is developed to estimate health-related quality of life (HRQOL) based on scores from eight domains and two summaries. Results obtained from the SF-8 show a high correlation with the SF-36. Scores for the physical and mental component summaries (MCS) are calculated according to the manual for the Japanese version of the SF-8. A score of 50 is the mean for the Japanese general population across the eight domains and two scores; lower scores indicate a poorer HRQOL. Therefore, we defined that an MCS \<50 defined poor mental status.

\(iv\) Laxative use (yes or no).

\(v\) Socioeconomic factors: marital status (married or not).

\(vi\) Previous history of cholecystectomy (yes or no).

\(vii\) Use of cigarettes and alcohol: current cigarette habit (yes/no) and alcohol (yes for current drinking habit, no for never or no current use).

\(viii\) Medication history.

Statistical analysis
--------------------

Statistical analysis was performed using Excel-Toukei 2010 software for Windows (Social Survey Research Information, Tokyo, Japan). Differences between the measured and group values were analyzed using the *χ*^2^-test and Student\'s *t*-test. A multivariable analysis was performed using a conditional logistic regression model, and *P* values \<0.05 were considered statistically significant.

RESULTS
=======

Location of DD and IBS
----------------------

[Figure 1](#fig1){ref-type="fig"} shows the flow diagram of this study. We initially enrolled 1,082 subjects and 73 subjects met the exclusion criteria. A final total of 1,009 subjects were enrolled in this study, and [Table 1](#tbl1){ref-type="table"} shows the patient characteristics. The male-to-female ratio was 1.62:1, with a mean age of 64.2±12.9 years (range, 20--85 years). [Table 2](#tbl2){ref-type="table"} shows a comparison of the IBS group (*n*=76) and the non-IBS group (*n*=933). The prevalence of laxative use (*P*=0.0010), MCS \<50 (*P*=0.0001), LD (*P*=0.0002), and BD (*P*=0.0307) had *P* values of \<0.05. We then performed a multiple logistic regression analysis using parameters with a *P* value of \<0.05 identified by univariate regression analysis in addition to the following parameters: ≦65 years of age, male, RD, and NSAID use (*P*=0.0654). [Table 3](#tbl3){ref-type="table"} shows the results of the multiple logistic regression analysis. Multiple logistic regression analysis showed MCS (\<50) (odds ratio: 3.7, 95% confidence interval (CI): 2.0--6.9, *P*=0.0001), LD (odds ratio: 3.1, 95% CI: 1.4--7.1, *P*=0.0060), and BD (odds ratio: 2.6, 95% CI: 1.3--5.2; *P*=0.0070) were independent risk factors for IBS. However, RD was not an independent risk factor for IBS (odds ratio: 0.9, 95% CI: 0.5--1.9, *P*=0.8873).

Location of DD and IBS subtype
------------------------------

We also studied the association between IBS subtype and DD location. We calculated the odds ratio for RD, LD, and BD, with relative risk of IBS subtype compared with no IBS group. [Table 4](#tbl4){ref-type="table"} shows the association between IBS subtype and location of DD. Left-sided DD was an independent risk factor for D-IBS and U-IBS (odds ratio: 8.8, 95% CI: 2.5--30.8; odds ratio: 3.1, 95% CI: 1.2--8.2, respectively).

DISCUSSION
==========

RD was identified in 21.6% of the subjects in our study, and LD and BD were identified in 6.6 and 12.0% of the subjects, respectively. IBS was diagnosed in 7.5% of the subjects ([Figure 2](#fig2){ref-type="fig"}), and a history of acute colonic diverticulitis was present in 5.2% of the subjects. We showed that LD and BD were independent risk factors for IBS, and we also showed that LD was associated with D-IBS and U-IBS. Our most interesting finding was that RD was not associated with IBS. It is difficult to explain why we found no relation between RD and IBS. However, we propose some hypotheses.

A difference in visceral hypersensitivity induced by DD is one hypothesis. Visceral hypersensitivity is also an important factor for development of IBS ([@bib15]). Patients with symptomatic uncomplicated DD were shown to have visceral hypersensitivity ([@bib16]). Visceral hypersensitivity has been reported to be caused by low-grade inflammation and neuropeptide changes ([@bib17], [@bib18]). The lack of visceral hypersensitivity in patients with RD may be due to differences between the dominant nerves of the colon on the proximal and distal sides. In the colon, afferent nerve fibers reach the central nervous system via parasympathetic pathways and spinal afferent nerves, both of which display mechano- and chemo-sensitivity ([@bib19]). The parasympathetic fibers convey sensory information from the proximal colon (cecum, ascending colon, and 2/3 of the transverse colon) via the vagus nerve to cell bodies in the nodose and jugular ganglia and from the distal colon (1/3 of the transverse colon, sigmoid colon, descending colon, and rectum) via the pelvic splanchnic nerves ([@bib19], [@bib20], [@bib21]). Enteric nerve changes caused by low-grade inflammation may vary according to the dominant nerve, which may explain the lack of relationship between IBS and RD. However, further investigations are necessary to prove this hypothesis.

When we studied the association between IBS subtype and location of DD, we showed that U-IBS and D-IBS were significantly associated with LD. Previous studies have also shown that D-IBS was associated with DD ([@bib5]). Our data showed that U-IBS was also significantly associated with LD, indicating the possibility that the impact of LD on IBS is related not only to bowel habits but also to other factors such as pain or discomfort.

Previous reports showed that psychosocial factors are important in the development of IBS ([@bib22]); therefore, we used MCS to evaluate mental health. Previously, Kaji *et al.* ([@bib23]) reported a positive association between low MCS and IBS patients overlapping Gastroesophageal reflux disease, functional dyspepsia, and our data showed that low MCS was an important factor in the development of IBS.

Our study has several limitations. First, our study target comprised subjects who underwent colonoscopy for colon and rectal cancer screening. Therefore, our study subjects may be more symptomatic compared with general populations. Second, it is said that the detection rate of diverticulum by colonoscopy was inferior compared with barium enema ([@bib24]). Therefore, for the purposes of accuracy, we used a transparent soft-short-hood on the scope for colonoscopy. Previous reports have shown that a transparent soft-short-hood allows detection of small lesions ([@bib25]). Third, the number of subjects with IBS was too small to draw conclusions about the association between IBS subtype and DD location. To address this limitation, we have been enrolling a larger number of study subjects to increase the accuracy. Fourth, the ratio of IBS subtype to gender in our study differed from previous reports. In Japan, D-IBS was common in males and constipation-predominant IBS was common in females in younger age groups ([@bib26]). However, our data showed that U-IBS was most common. This is likely because the average age of our subjects was higher than that of the peak age at onset. Fifth, the classification of IBS based on patient recall is highly inaccurate. It may have been better to use a 7-day stool diary, allowing investigators to classify each subject\'s bowel habits ([@bib27]). Sixth, we found that the proportion of males was higher compared with females in our study cohort. Probably, this is because of social background in Japan, in that more asymptomatic males than females undergo a total colonoscopy for colorectal cancer screening ([@bib28]).

In summary, our data showed that the presence of LD and BD was both associated with a higher risk of IBS. However, RD showed no relationship with IBS. Therefore, differences in pathological factors caused by the location of the DD are important in the development of IBS. Clarifying the specific changes associated with left-sided DD could provide a better understanding of the pathogenic mechanisms of IBS.

Study Highlights
================
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###### Patients\' characteristics

                                            ***n*****=1,009**
  ----------------------------------------- -------------------
  Age (s.d.; years)                         64.2±12.9
  Gender (M:F)                              1.62:1
  Mean BMI (s.d.)                           22.9±3.5
  Smoker %                                  17.4
  Alcohol %                                 41.8
  Laxative use %                            14.8
  NSAIDs %                                  1.5
  Aspirin %                                 7.0
  Previous cholecystectomy %                5.0
  History of acute colonic diverticulitis   5.2%
  Married %                                 79.6
  MCS (\<50) %                              51.4
  RD                                        21.6%
  LD                                        6.6%
  BD                                        12.0%
  IBS                                       7.5%

BD, bilateral diverticular disease; BMI, body mass index; IBS, irritable bowel syndrome; LD, left-sided diverticular disease; MCS, mental component summary; n, number; NSAID, non-steroidal anti-inflammatory drug; RD, right-sided diverticular disease.

###### Comparison of the IBS group and non-IBS group

                                            **IBS (*****n*****=76)**   **non-IBS (*****n*****=933)**   ***P*** **value**
  ----------------------------------------- -------------------------- ------------------------------- -------------------
  Age (s.d.; years)                         65.8±13.7                  64.1±12.8                       0.2649^S^
  ≤65 years                                 64.5%                      56.6%                           0.1818^C^
  Gender (M:F)                              1.17:1                     1.67:1                          0.1406^C^
  Mean BMI (s.d.)                           22.4±3.4                   23.0±3.5                        0.1822^S^
  Smoker %                                  14.5                       17.8                            0.4645^C^
  Alcohol %                                 42.1                       41.8                            0.9587^C^
  Laxative use %                            27.6                       13.7                            0.0010^C^\*
  NSAIDs %                                  3.9                        1.3                             0.0653^C^
  Aspirin %                                 7.7                        7.0                             0.7610^C^
  Previous cholecystectomy %                3.9                        5.0                             0.6737^C^
  History of acute colonic diverticulitis   2.6%                       5.4%                            0.3011^C^
  Married %                                 77.6                       80.9                            0.4848^C^
  MCS (\<50) %                              79.1                       49.0                            0.0001^C^\*
  RD                                        18.4%                      21.9%                           0.4830 ^C^
  LD                                        18.4%                      5.68%                           0.0002^C^\*
  BD                                        19.7%                      11.4%                           0.0307^C^\*

BD, bilateral diverticular disease; BMI, body mass index; IBS, irritable bowel syndrome; LD, left-sided diverticular disease; MCS, mental component summary; n, number; NSAID, non-steroidal anti-inflammatory drug; RD, right-sided diverticular disease. C χ2-Test, S Student\'s t test. \*(P \< 0.05).

###### Results of the multiple logistic regression analysis for independent risk for IBS

               Odds ratio   95% CI     *P* value
  ------------ ------------ ---------- -----------
  Male         0.7          0.4--1.1   0.1466
  ≤65 years    1.2          0.7--2.0   0.5863
  NSAIDs       2.0          0.5--8.1   0.3069
  MCS (\<50)   3.7          2.0--6.9   0.0001\*
  RD           0.9          0.5--1.9   0.8873
  LD           3.1          1.4--7.1   0.0060\*
  BD           2.6          1.3--5.2   0.0070\*

CI, confidence interval; NSAID, non-steroidal anti-inflammatory drug; MCS, mental component summary; RD, right-sided diverticular disease; LD, left-sided diverticular disease; BD, bilateral diverticular disease. \*(P \< 0.05).

###### Association between IBS subtype and location of DD

               **RD (*****n*****=218)**            **LD (*****n*****=67)**              **BD (*****n*****=121)**   
  ----------- -------------------------- -------- ------------------------- ---------- -------------------------- --------
  D-IBS (%)              1.4                                 9.0                                  2.5              
                    1.3 (0.3--5.1)        0.7041       8.8 (2.5--30.8)       0.0006\*       2.8 (0.7--11.3)       0.1524
  C-IBS (%)              0.9                                 1.5                                  1.7              
                    1.5 (0.3--8.1)        0.653        2.3 (0.3--21.1)        0.4621        2.7 (0.5--14.9)       0.2574
  M-IBS (%)              0.9                                 1.5                                  1.7              
                   5.5 (0.5--60.8)        0.1674      8.2 (0.5--138.7)        0.1466        9.2 (0.8--104.3)      0.0726
  U-IBS (%)              3.2                                 9.0                                  6.6              
                    0.9 (0.4--2.2)        0.8806       3.1 (1.2--8.2)        0.0235\*        2.1 (0.9--4.8)       0.1021

BD, bilateral diverticular disease; CI, confidence interval; C-IBS, constipation-predominant IBS; DD, diverticular disease; IBS, irritable bowel syndrome; LD, left-sided diverticular disease; M-IBS, mixed IBS; n, number; OR, odds ratio; RD, right-sided diverticular disease; U-IBS, un-subtype IBS.
